June 5, 2025

A recent study led by Oregon Health & Science University (OHSU) has identified a natural compound that could potentially halt the progression of multiple sclerosis (MS) and certain forms of cancer. The research, published in the Journal of Biological Chemistry, focuses on a plant-derived flavonoid called sulfuretin.

Key findings of the study include:

  • Sulfuretin blocks the activity of an enzyme involved in MS and cancer progression.
  • The compound inhibits a specific type of hyaluronidase known as CEMIP.
  • By inhibiting CEMIP, sulfuretin may prevent the breakdown of hyaluronic acid, which is associated with myelin damage and cancer cell proliferation.

Dr. Larry Sherman, professor at OHSU’s Oregon National Primate Research Center, believes this discovery could have a significant impact on various medical conditions. The research team found that sulfuretin, along with two synthetic compounds, effectively inhibited hyaluronidase activity in live cells.

The study is the result of years of collaborative work between OHSU and the University of Portland, where undergraduate students under the guidance of Dr. Angela Hoffman screened numerous plant compounds. This discovery validates the students’ diligent efforts and highlights the importance of undergraduate research in scientific breakthroughs.

While the results are promising, further testing in animal models is necessary to determine the compound’s effectiveness and potential side effects in treating cancer and neurodegenerative conditions like MS.

This research opens new possibilities for treating a range of disorders, including osteoarthritis, skin infections, and brain injuries caused by heavy alcohol use. As the study progresses, it brings hope for improved treatments for MS, cancer, and other conditions related to hyaluronic acid breakdown.

Back to top